Consolidated Income Statement

€ million	Note	2016	2015
Net sales	➞ 7	15,024	12,845
Cost of sales	➞ 8	– 5,201	– 4,076
(of which: amortization of intangible assets)¹		(– 181)	(– 167)
Gross profit		9,823	8,768

Marketing and selling expenses	➞ 9	– 4,526	– 4,050
(of which: amortization of intangible assets)¹		(– 1,032)	(– 779)
Administration expenses		– 854	– 720
Research and development costs	➞ 10	– 1,976	– 1,709
(of which: amortization of intangible assets)¹		(– 4)	(– 3)
Other operating income	➞ 11	996	471
Other operating expenses	➞ 12	– 981	– 917
Operating result (EBIT)		2,481	1,843

Financial result	➞ 13	– 326	– 357
Profit before income tax		2,154	1,487

Income tax	➞ 14	– 521	– 368
Profit after tax from continuing operations		1,633	1,118
Profit after tax from discontinued operations		–	6
Profit after tax		1,633	1,124

of which: attributable to Merck KGaA shareholders (net income)		1,629	1,115
of which: attributable to non-controlling interests	➞ 24	4	9

Earnings per share (in €)	➞ 15
basic		3.75	2.56
– thereof: from continuing operations		3.75	2.55
– thereof: from discontinued operations		–	0.01

diluted		3.75	2.56
– thereof: from continuing operations		3.75	2.55
– thereof: from discontinued operations		–	0.01
¹ Excluding amortization of internally generated or separately acquired software.